Navigation Links
Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis
Date:5/21/2012

ROCHESTER, Minn. Heart disease risk assessment tools commonly used by physicians often underestimate the cardiovascular disease danger faced by rheumatoid arthritis patients, a Mayo Clinic study has found. Inflammation plays a key role in putting those with rheumatoid arthritis in greater jeopardy for heart disease, yet many cardiovascular disease risk assessment methods do not factor it in, the researchers note. More work is needed to figure out what drives heart disease in rheumatoid arthritis patients, and more accurate tools to assess that risk should be developed, the authors say. The study is published online in the American Journal of Cardiology.

In rheumatoid arthritis, the immune system attacks tissues, inflaming joints. It can also affect other parts of the body. Rheumatoid arthritis patients have a higher risk of early death than the general population, and previous research suggests cardiovascular disease is the main reason. The Mayo study gauged the accuracy of two commonly used tools for assessing heart disease danger the Framingham and Reynolds risk scores and found they substantially underrated cardiovascular disease danger in women and men with rheumatoid arthritis, particularly in older patients and people who test positive for rheumatoid factors, proteins produced by the immune system and often associated with rheumatoid arthritis.

"This study emphasizes that patients with rheumatoid arthritis are at higher risk for heart disease, and that conventional predictors of risk are not adequate for estimating this risk. Physicians caring for patients with rheumatoid arthritis should be aware of this heightened risk even when conventional risk factors seem to indicate no increased risk, and consider measures to assess and lower CV risk in these patients," says co-author Eric Matteson, M.D., chairman of Mayo Clinic's rheumatology division.

Among those studied were 525 patients over 30 who were diagnosed with rheumatoid arthritis between 1988 and 2007 and had no previous history of cardiovascular disease. The study used medical records from the National Institutes of Health-funded Rochester Epidemiology Project, whose resources make Olmsted County, Minn., one of the few places in the world where researchers can examine medical data on virtually everyone in a defined geographic population to find the true frequency of certain conditions and the success of treatments.

The patients' 10-year risk of developing cardiovascular disease was measured using the Framingham and Reynolds risk scores. The mean follow-up period was 8.4 years; 84 patients developed cardiovascular disease during that time. The observed heart disease risk turned out to be twice as high among women and 65 percent higher in men than the Framingham risk score predicted, and the Reynolds tool had similar shortcomings, researchers found. Patients 75 and older proved to be three times more at risk than the Framingham score indicated. Patients with positive rheumatoid factor also had more heart disease events than the risk scores predicted.

"Ongoing research is attempting to determine how inflammation leads to increased cardiovascular risk in rheumatoid arthritis, and what treatments for rheumatoid arthritis might reduce this risk," Dr. Matteson says. "Further work must also evaluate just how patients with rheumatoid arthritis should be managed to detect and reduce their risk for cardiovascular disease."


'/>"/>

Contact: Sharon Theimer
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Atlanta School of Massage Celebrates 30th Anniversary with a New Green Design and New Name for its Teaching Clinic: SensAbility
2. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
3. Mayo Clinic: Flaxseed no cure for hot flashes during breast cancer or menopause
4. Mayo Clinic: Primary physicians may hold key to suicide prevention
5. Mayo Clinic: Short training course significantly improves detection of precancerous polyps
6. Mayo Clinic: Young women with rheumatoid arthritis at more risk for broken bones
7. Mayo Clinic: Obese patients with HER2-positive breast cancer may have worse outcomes
8. Mayo Clinic: How patients will respond to immunomodulator therapy for multiple myeloma
9. Mayo Clinic: Hospitalization of US underage drinkers common, costs $755 million a year
10. Mayo Clinic: Robotic surgery proves successful, less invasive way to treat HPV-related oral cancer
11. Mayo Clinic: Obesity epidemic fueling rise in rheumatoid arthritis among women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 23, 2017 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it had won the ‘Clinical Supply ... the Suntec Singapore International Exhibition & Convention Centre, Singapore. The award was presented ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... and this tool bypasses that. Healthcare facilities across the country are always ... offer their clients and hospitals, across the country, an efficient and quick way ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome ... devastating neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused ... almost exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect ...
(Date:3/22/2017)... ... March 22, 2017 , ... Last year, 43 million gallons of surplus milk ... report. While excess dairy can be caused by several factors, one pharmaceutical company ... inability to properly digest lactose, a sugar found in milk and milk products. ...
(Date:3/22/2017)... Prairie, TX (PRWEB) , ... March 22, 2017 ... ... providing insurance consultation, financial planning, and related services to communities across eastern Texas, ... with the goal of providing meals to hungry children and adults. , ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... --  Upsher-Smith Laboratories, Inc . (Upsher-Smith) today announced the U.S. ... and 75 mg, the generic equivalent to Mallinckrodt Pharmaceuticals, Anafranil ... clomipramine hydrochloride capsules market had U.S. sales of approximately $172 ... IMS Health. ... "Upsher-Smith has long been recognized within the pharmaceutical industry ...
(Date:3/22/2017)... BROOK, N.Y. , March 22, 2017  As ... The Leukemia & Lymphoma Society (LLS) has played a ... cancer patients, some of which are even helping patients ... possible due to LLS,s significant investment in cutting-edge research ...  That milestone continues to grow with the record-breaking sum ...
(Date:3/22/2017)...  Levine Cancer Institute today launched the first ... address lung cancer diagnosis, treatment and survival disparities ... lung unit is the first-of-its-kind to link rural ... through integrated mobile technology, traditional treatment facilities and ... a lack of public transportation are barriers to ...
Breaking Medicine Technology: